Supplement Scholar
Metabolic / Amylin

Cagrilintide

Research compound. This is not a dietary supplement. Unless it is identified as an approved prescription drug, it is not approved by the FDA for human use. This page summarizes published research for education only; we do not sell it or link to sellers.

Cagrilintide. Long-acting amylin analog studied in combination with semaglutide for weight loss.

How it works. Activates amylin and calcitonin receptors to slow gastric emptying, increase satiety, and suppress glucagon.

What the research supports. 2 graded claims. Strongest: Complementary mechanism to GLP-1 agonists (preclinical).

Hormonal impact. Effects on Amylin signaling, Glucagon, Leptin sensitivity.

Side effects and interactions. 1 medication interaction listed. Serious: Pancreatitis risk in combination therapy under study.

Stacking. Pairs well with Semaglutide. Avoid combining with Personal history of medullary thyroid cancer.

Common forms. Available as Subcutaneous injection.

Community. Experiences from people who have tried Cagrilintide. Anecdotes are not medical advice.

Cagrilintide. Long-acting amylin analog studied in combination with semaglutide for weight loss.

No single structure

What it is

Cagrilintide is a long-acting amylin analog designed for once-weekly dosing, most commonly studied as 'CagriSema' with semaglutide.

Also called

AM833

How it works

Activates amylin and calcitonin receptors to slow gastric emptying, increase satiety, and suppress glucagon.

Pathways

  • Amylin receptor
  • Calcitonin receptor
  • Vagal satiety signaling

Effects

  • ↓Appetite and food intake decreases
  • +Postprandial glycemic control supports

What the research supports

Complementary mechanism to GLP-1 agonistspreclinical
Weekly dosingpreclinical

Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.

Hormonal impact

↑Amylin signalingincreases
↓Glucagondecreases
~Leptin sensitivitymodulates

Side effects & interactions

Common side effects

  • Nausea
  • Decreased appetite

Serious

  • Pancreatitis risk in combination therapy under study

Medication interactions

Insulinmoderate

Risk of hypoglycemia when stacked.

Check any supplement–medication combination with your pharmacist before starting.

Combines with

Pairs well

  • SemaglutideStudied combination with additive weight loss.

Avoid combining

  • Personal history of medullary thyroid cancerClass-level caution with GLP-1/calcitonin-axis drugs.

Common forms

  • Subcutaneous injection

Discussion

Loading discussion…